2004;286:E621E625
Other Reported Vision Issues From Wegovy In addition to NAION, people with diabetes or cardiovascular risk factors who take Wegovy may still be at risk for other common eye conditions such as diabetic retinopathy, macular edema, or ocular migraines (although these conditions can occur in people not taking Wegovy)
Benjamin EJ, Muntner P, Alonso A, Bittencourt MS, Callaway CW, Carson AP, et al
The organization also makes clear that health insurance plans may not cover the surgery or its complications
Availability: The Number That Determines Most Decisions Semaglutide (Wegovy): FDA approved June 2021
One trial showed that the creatine group lost 7.2% body fat versus 5.1% in the placebo group over 12 weeks, despite similar total weight loss